Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 87.60M | £ 24.00M | £ 71.10M | £ 40.90M | £ 109.20M |
Total Assets | £ 1.97B | £ 1.79B | £ 1.75B | £ 1.55B | £ 1.70B |
Total Debt | £ 679.20M | £ 655.20M | £ 654.20M | £ 704.40M | £ 744.50M |
Net Debt | £ 591.60M | £ 631.20M | £ 583.10M | £ 663.50M | £ 635.30M |
Total Liabilities | £ 1.48B | £ 1.34B | £ 1.33B | £ 1.23B | £ 1.33B |
Stockholders Equity | £ 488.00M | £ 450.60M | £ 420.30M | £ 321.10M | £ 375.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |